Medical Editor: John P. Cunha, DO, FACOEP
Obredon (hydrocodone bitartrate and guaifenesin) Oral Solution is a combination opioid antitussive and expectorant used for symptomatic relief of cough and to loosen mucus associated with the common cold. Common side effects of Obredon include:
- decreased blood pressure, and
- hot flashes
The recommended adult dose of Obredon is 10 mL every 4 to 6 hours, not to exceed 6 doses (60 mL) in 24 hours. Obredon may interact with opioids, antihistamines, antipsychotics, anti-anxiety agents, other CNS depressants, MAOIs, and anticholinergics. Tell your doctor all medications and supplements you use. During pregnancy, Obredon should be taken only if prescribed. Hydrocodone passes into breast milk. Obredon is not recommended for use while breastfeeding. Withdrawal symptoms may occur if you suddenly stop taking this medication.
Our Obredon (hydrocodone bitartrate and guaifenesin) Oral Solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Use of hydrocodone bitartrate is associated with the following:
- Respiratory depression [see WARNINGS AND PRECAUTIONS and OVERDOSAGE]
- Drug dependence [see WARNINGS AND PRECAUTIONS and Drug Abuse And Dependence]
- Increased intracranial pressure [see WARNINGS AND PRECAUTIONS]
- Decreased mental alertness with impaired mental and/or physical abilities [see WARNINGS AND PRECAUTIONS]
- Paralytic ileus [see WARNINGS AND PRECAUTIONS]
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.
The most common adverse reactions experienced by subjects taking a single dose of OBREDON Oral Solution in the clinical setting include the following: Central Nervous System: headache, dizziness, sedation (somnolence); Gastrointestinal System: nausea, diarrhea; Cardiovascular System: decreased blood pressure; Vascular System: hot flush.
Read the entire FDA prescribing information for Obredon (Hydrocodone Bitartrate and Guaifenesin Oral Solution)
© Obredon Patient Information is supplied by Cerner Multum, Inc. and Obredon Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.